StreetInsider.com News Articles

PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

Tue, 11 Mar 2025 07:05:00 -0400

Former Baxter and Baxalta Chief Financial Officer brings more than 30 years of biotech financial and operational experience

BOSTON--(BUSINESS WIRE)-- PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company, noted that its Founded Entity, Seaport Therapeutics, (“Seaport”) a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced that Robert “Bob” J. Hombach has been appointed to its Board of Directors and will serve as the Chair of the Audit Committee. Mr. Hombach is a seasoned

PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

Tue, 11 Mar 2025 07:05:00 -0400

Former Baxter and Baxalta Chief Financial Officer brings more than 30 years of biotech financial and operational experience

PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

Tue, 11 Mar 2025 07:05:00 -0400

Former Baxter and Baxalta Chief Financial Officer brings more than 30 years of biotech financial and operational experience

PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

Tue, 11 Mar 2025 07:05:00 -0400

Former Baxter and Baxalta Chief Financial Officer brings more than 30 years of biotech financial and operational experience

PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

Tue, 11 Mar 2025 07:05:00 -0400

Former Baxter and Baxalta Chief Financial Officer brings more than 30 years of biotech financial and operational experience

PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

Tue, 11 Mar 2025 07:05:00 -0400

Former Baxter and Baxalta Chief Financial Officer brings more than 30 years of biotech financial and operational experience

PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

Tue, 11 Mar 2025 07:05:00 -0400

Former Baxter and Baxalta Chief Financial Officer brings more than 30 years of biotech financial and operational experience

PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

Tue, 11 Mar 2025 07:05:00 -0400

Former Baxter and Baxalta Chief Financial Officer brings more than 30 years of biotech financial and operational experience

PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

Tue, 11 Mar 2025 07:05:00 -0400

Former Baxter and Baxalta Chief Financial Officer brings more than 30 years of biotech financial and operational experience

PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

Tue, 11 Mar 2025 07:05:00 -0400

Former Baxter and Baxalta Chief Financial Officer brings more than 30 years of biotech financial and operational experience

PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

Tue, 11 Mar 2025 07:05:00 -0400

Former Baxter and Baxalta Chief Financial Officer brings more than 30 years of biotech financial and operational experience

PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

Tue, 11 Mar 2025 07:05:00 -0400

Former Baxter and Baxalta Chief Financial Officer brings more than 30 years of biotech financial and operational experience

PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

Tue, 11 Mar 2025 07:05:00 -0400

Former Baxter and Baxalta Chief Financial Officer brings more than 30 years of biotech financial and operational experience

PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

Tue, 11 Mar 2025 07:05:00 -0400

Former Baxter and Baxalta Chief Financial Officer brings more than 30 years of biotech financial and operational experience

PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

Tue, 11 Mar 2025 07:05:00 -0400

Former Baxter and Baxalta Chief Financial Officer brings more than 30 years of biotech financial and operational experience

PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

Tue, 11 Mar 2025 07:05:00 -0400

Former Baxter and Baxalta Chief Financial Officer brings more than 30 years of biotech financial and operational experience

PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

Tue, 11 Mar 2025 07:05:00 -0400

Former Baxter and Baxalta Chief Financial Officer brings more than 30 years of biotech financial and operational experience

PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

Tue, 11 Mar 2025 07:05:00 -0400

Former Baxter and Baxalta Chief Financial Officer brings more than 30 years of biotech financial and operational experience

PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

Tue, 11 Mar 2025 07:05:00 -0400

Former Baxter and Baxalta Chief Financial Officer brings more than 30 years of biotech financial and operational experience

PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

Tue, 11 Mar 2025 07:05:00 -0400

Former Baxter and Baxalta Chief Financial Officer brings more than 30 years of biotech financial and operational experience

PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

Tue, 11 Mar 2025 07:05:00 -0400

Former Baxter and Baxalta Chief Financial Officer brings more than 30 years of biotech financial and operational experience

PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

Tue, 11 Mar 2025 07:05:00 -0400

Former Baxter and Baxalta Chief Financial Officer brings more than 30 years of biotech financial and operational experience

PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

Tue, 11 Mar 2025 07:05:00 -0400

Former Baxter and Baxalta Chief Financial Officer brings more than 30 years of biotech financial and operational experience

PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

Tue, 11 Mar 2025 07:05:00 -0400

Former Baxter and Baxalta Chief Financial Officer brings more than 30 years of biotech financial and operational experience

PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

Tue, 11 Mar 2025 07:05:00 -0400

Former Baxter and Baxalta Chief Financial Officer brings more than 30 years of biotech financial and operational experience